Navigation Links


Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas

5/24/2013
CHAPEL HILL, N.C. , May 24, 2013  Regulatory and marketplace changes have pushed Medical Affairs to the forefront of many organizations' priority list. Forward-thinking companies across the biopharmaceutical and medical device sectors understand a strong Medical Affairs function is essential to meeting current challenges in clinical development, market education , an... [Comments]

BD to Present at the Deutsche Bank 38th Annual Health Care Conference

5/24/2013
FRANKLIN LAKES, N.J. , May 24, 2013  BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today that it will present at the Deutsche Bank 38 th Annual Health Care Conference on Thursday, May 30, 2013, at 10:40 a.m. (ET). A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/... [Comments]

Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg

5/24/2013
BEVERLY HILLS, Calif. , May 24, 2013 /PRNewswire-iReach/ -- Phoenix Houses of California , the state's leading non-profit substance abuse services organization, is hosting its tenth annual "Triumph For Teens" Awards Gala at the Beverly Hills Hotel on June 6, 2013.  More than 300 people are expected to attend the event to raise funds for the adolescent residential treatment centers, fa... [Comments]

Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.

5/24/2013
HAYWARD, Calif. , May 24, 2013 Solta Medical, Inc. (NASDAQ: SLTM ), a global leader in the medical aesthetics market, today reported Dr. Edward W. Knowlton has resigned as a member of the Company's Board of Directors effective immediately.  Dr. Knowlton is the founder of Thermage, the predecessor company to Solta Medical and had served as a director since 1996. "O... [Comments]

International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma

5/24/2013
LOS ANGELES , May 24, 2013  An international roster of experts on malignant pleural mesothelioma (MPM) gathered on Saturday, May 18, in Santa Monica, Calif. , to discuss their latest research findings on new lung-sparing therapies for MPM, a rare form of cancer that results from exposure to asbestos and commonly affects the pleura, the lining of the chest. Hosted by U... [Comments]

Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference

5/24/2013
LOVELAND, Colo. , May 24, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today that Dr. Robert Grieve , the Company's chairman and chief executive officer, and Jason Napolitano , executive vice president and chief financial officer, will present at the Second Annual Marcu... [Comments]

China Biologic Comments on the Proposed Shanghai RAAS Transaction

5/24/2013
BEIJING , May 24, 2013 China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company has recently learned from a public announcement issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai RAAS"), a public company listed on Shenzhen... [Comments]

Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference

5/24/2013
CHESTERBROOK, Pa. , May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) today announced that executive management will participate in the Deutsche Bank Health Care Conference to be held May 29-30 at the Westin Boston Waterfront Hotel.  Mr. Adrian Adams , Chief Executive Officer and President, is scheduled to present an overview of the Company and its pro... [Comments]

Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements

5/24/2013
NEW YORK , May 24, 2013 In accordance with Rule 17.1 and Rule 2.9 of the Irish Takeover Rules and Rule 14e-1 of the United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") today announced acceptance levels its original offer for Elan Corporation (NYSE: ELN). Background On 2 May 2013, Echo Pharma Acquisition Limited ("Royalty Pharma") made an offer fo... [Comments]

Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines

5/24/2013
BEIJING , May 24, 2013  Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading provider of biopharmaceutical products in China , announced that Sinovac Beijing, the main operating subsidiary company of Sinovac, obtained the Certificate of Good Manufacturing Practices for Pharmaceutical Products (GMP Certificate) from the China State and Food Administration (CFDA) for its prop... [Comments]

[next]
(Date:5/24/2013)... E-Dentists.com has announced the launch of their new ... a leading medical Internet marketing agency. , ... focus on providing dentists the help they need to ... keywords. The dental SEO analysis covers a full analysis ... their competitors are doing right. The goal is to ...
(Date:5/24/2013)... Started in 1982, AMTC’s SHINE event is a ... AMTC’s 31st anniversary. SHINE is a ministry run by three ... and her daughter, Carey Lewis Arban. , This summer’s SHINE ... music professionals including the New York Film Academy, The New ... kings of Hollywood and Christian casting directors. They seek ...
(Date:5/24/2013)... Utah (PRWEB) May 24, 2013 Amirsys ... with exciting new enhancements for instructors and students. Instructors ... more focused through personalize learning plan templates, targeted reading ... release provides 500 new assessment questions, 5,000 searchable anatomy ... notes. , AnatomyOne 2.0 is the first ...
(Date:5/24/2013)... Dwell Media LLC announces ... Executive Vice President of Digital for Dwell Media. At ... a large portion of Yahoo's global media business. At ... a fully-integrated commerce unit to launch in 2014. Huff ... content for leading firms in Silicon Valley. Dwell, which ...
(Date:5/24/2013)... (HealthDay News) -- Low-income, minority parents have more ... are more open to vaccinating their daughters against ... new study contends. Conversely, white, middle-class parents ... their daughters, according to researchers from the Boston ... will get an HPV-related cancer each year, many ...
Breaking Medicine News(10 mins):Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:Low-Income, Minority Parents More Open to HPV Vaccine for Girls, Study Says 2
... PCYC ) today announced that it will ... 2008 financial results and achievements on,Thursday, April 24, ... To participate in the conference call, please ... callers and reference,conference passcode, 43624853. To access the ...
... in addressing the problem, ALEXANDRIA, Va., April ... the only national organization,representing physician assistants (PA) in ... in on the challenges outlined in the,Institute of ... workforce,and aging baby boomers. There are an estimated ...
... the male hormone in the morning made more money , , ... Britain finds that financial traders who wake up with high ... money that day, probably because they feel more daring. ... the stress hormone cortisol tend to be more cautious. , ...
... DETROIT, April 14 A unique global conference,focusing ... Detroit June 8 - 10,2009. The HealthQuake Summit ... world to gather and explore the ongoing and ... areas of business, policy, and,science/technology that will make ...
... Passover, ATLANTA, April 14 As Americans travel ... for Disease Control,and Prevention advises all travelers to ensure ... measles outbreak in Israel., Since September, more than ... about 700 cases in the cities of Jerusalem and ...
... half the risk of needing to start treatment , , ... levels of the antioxidant urate in their blood appear to ... lower levels do, a new report says. , The findings, ... Neurology , support early laboratory studies about urate,s protective qualities ...
Cached Medicine News:Health News:Health Care Workforce Experts Available to Comment on IOM Report on Aging Baby Boomers and Impending Medical System Crisis 2Health News:Testosterone Levels Among Financial Traders Affect Performance 2Health News:Testosterone Levels Among Financial Traders Affect Performance 3Health News:CDC Urges Travelers to Israel to Protect Themselves from Measles 2Health News:Elevated Urate Levels May Slow Parkinson's in Men 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products:
(Date:5/23/2013)... -- Hearing health affects a man,s lifestyle, and if he ... professionally engaged, he should address any hearing loss he may ... Better Hearing Institute (BHI) is delivering to men around ... , which leads up to and includes Father,s Day. This ... June 16. To help men address their ...
(Date:5/23/2013)... -- A recently published clinical study conducted at TOPS Comprehensive ... demonstrates that 3D mammography (breast tomosynthesis) significantly reduces unnecessary ... The study, "Implementation of Breast Tomosynthesis in a Routine ... Stephen L. Rose , MD, and published ... of Roentgenology (AJR). The AJR is the scientific ...
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... blood,pressure, reduces blood flow in the brains of adults ... at the annual meeting of,the Radiological Society of North ... of Alzheimer,s disease, our study,shows that it is another ... effects of the disease," said study co-author Cyrus Raji, ...
... 28 Immunosyn,Corporation (OTC Bulletin Board: IMYN) today ... MHRA to import base material,and manufacture SF-1019 for ... for which Immunosyn holds the exclusive license for,worldwide ... Regulatory Agency," more,commonly known as the MHRA, functions ...
Cached Medicine Technology:High Blood Pressure May Heighten Effects of Alzheimer's Disease 2Immunosyn Announces Biozyme Lab's Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019 2Immunosyn Announces Biozyme Lab's Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019 3